Willis V. Burton - Concepedia

Author

Willis V. Burton

Alexion Pharmaceuticals (United States)

Also Known As

W Burton, W V Burton, W. Burton, WILLIS V. BURTON, WL Burton, William Burton, Willis V. Burton

Publications

628

Citations

H-Index

Concepts

All Affiliations

Alexion Pharmaceuticals (United States)Alexion Pharma (Switzerland)Alexion Pharmaceuticals (France)University of Connecticut Yale University

About

Willis V. Burton is an author at Alexion Pharmaceuticals (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	509
2	Natural Sciences	1	1	89
3	Social Sciences	1	1	180
4	Allergy	1	1	89
5	Biochemistry	1	1	89

Willis V. Burton

Publications

628

Citations

H-Index

Page 1

	Year	Citations
Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord Toshio Imaizumi, Karen L. Lankford, Willis V. Burton, Nature Biotechnology Regenerative MedicineNeuroregenerationXenotransplantationTransgenic Pig OlfactoryRat Spinal Cord	2000	180
Expression of the human α:1,2‐fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum‐mediated cytolysis Cristina Costa, Lisa Zhao, Willis V. Burton, The FASEB Journal HistocompatibilityGlycobiologyImmunologyHuman α:1,2‐FucosyltransferaseTissue Transplantation	1999	89
The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity William L. Fodor, Scott A. Rollins, Stella Bianco-Caron, Journal of Virology Herpesvirus SaimiriComplement SystemMolecular VirologyMedicinePathogenesis	1995	85
Transgenic pigs designed to express human CD59 and H‐transferase to avoid humoral xenograft rejection Cristina Costa, Lisa Zhao, Willis V. Burton, Xenotransplantation	2002	60
Extracellular matrix synthesis by skeletal muscle in culture. Proteins and effect of enzyme degradation. Robert L. Beach, Willis V. Burton, W J Hendricks, Journal of Biological Chemistry	1982	48
PROTECTION OF PORCINE AORTIC ENDOTHELIAL CELLS FROM COMPLEMENT-MEDIATED CELL LYSIS AND ACTIVATION BY RECOMBINANT HUMAN CD59 Scott P. Kennedy, Scott A. Rollins, Willis V. Burton, Transplantation ImmunologyPathologyImmunologic MechanismTissue TransplantationImmunotherapy	1994	48
PROTECTION OF PORCINE AORTIC ENDOTHELIAL CELLS FROM COMPLEMENT-MEDIATED CELL LYSIS AND ACTIVATION BY RECOMBINANT HUMAN CD59 SCOTT P. KENNEDY, Scott A. Rollins, Willis V. Burton, Transplantation ImmunologyImmunologic MechanismTissue TransplantationBiomedical EngineeringImmunotherapy	1994	42
Immune parameters relevant to neural xenograft survival in the primate brain Francesca Cicchetti, William L. Fodor, Terrence W. Deacon, Xenotransplantation Neural Xenograft SurvivalImmunologyImmune RegulationTransplantation MedicineImmunotherapy	2003	34
Primate terminal complement inhibitor homologues of human CD59 William L. Fodor, Scott A. Rollins, Stella Bianco-Caron, Immunogenetics Complement SystemHuman Cd59ImmunologyAntigen ProcessingAutoimmunity	1995	20
Proteoglycan synthesis by clonal skeletal muscle cells during <i>in vitro</i> myogenesis: Differences detected in the types and patterns from primary cultures Raymond R. Miller, Jasti S. Rao, Willis V. Burton, International Journal of Developmental Neuroscience	1991	11

Page 1